Citation Impact
Citing Papers
Oil-in-Water Emulsion MF59 Increases Germinal Center B Cell Differentiation and Persistence in Response to Vaccination
2015
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Toxicity, mechanism and health effects of some heavy metals
2014 Standout
Biomimetic nanoparticles: preparation, characterization and biomedical applications
2010
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
2008
Use of mass media campaigns to change health behaviour
2010 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
The BCG Story: Lessons from the Past and Implications for the Future
1989
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
2002 Standout
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
2009 Standout
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
2007
An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency Virus
1992 Standout
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Top ten biotechnologies for improving health in developing countries
2002
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
2007
Bioneedles as alternative delivery system for hepatitis B vaccine
2010
The burden of non-communicable diseases in South Africa
2009 Standout
A thermostable messenger RNA based vaccine against rabies
2017
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
HIV-related pulmonary disorders: practice issues
2007
New horizons in adjuvants for vaccine development
2020
Vitamin A, Immunity, and Infection
1994
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012
2014 Standout
Attitudes to vaccination: A critical review
2014 Standout
Patterned Paper as a Platform for Inexpensive, Low‐Volume, Portable Bioassays
2007 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Psychological flexibility as a fundamental aspect of health
2010 Standout
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
1998 Standout
Guideline for Infection Control in Healthcare Personnel, 1998
1998
Determinants of infant and early childhood mortality in Cameroon: The role of socioeconomic factors, housing characteristics, and immunization status
1994
Maternal and neonatal tetanus
2007
Prevalence of protective antibody against measles in HIV‐infected children with immune recovery after highly active antiretroviral therapy
2006
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
2015
Immunopathology of multiple sclerosis
2015 Standout
Addressing the vaccine confidence gap
2011
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Myocarditis
2011 Standout
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
New horizons in adjuvants for vaccine development
2008
HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action
2003 Standout
Safety and immunogenicity of measles–mumps–rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome)
2004
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
2008
Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis
2005
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
2012 Standout
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose
2004
Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa
2010
Indicators of socioeconomic position (part 1): Figure 1
2005 Standout
Immune Responses to Measles and Tetanus Vaccines Among Kenyan Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Children Pre- and Post-Highly Active Antiretroviral Therapy and Revaccination
2009
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
Pulmonary vaccine delivery
2007
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
2010
New use of BCG for recombinant vaccines
1991 StandoutNature
Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
2011
Tuberculosis and human immunodeficiency virus infection in developing countries
1990
Microneedles for drug and vaccine delivery
2012 Standout
Identification of an association between HLA class II alleles and low antibody levels after measles immunization
2001
Guideline for infection control in health care personnel, 1998
1998
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
2008
Needle-free vaccine delivery☆
2006
Leprosy among the limba: Illness and healing in the context of world view
1996
Inactivated Polio Vaccine (IPV): A strong candidate vaccine for achieving global polio eradication program
2009
Human health implications of environmental contaminants in Arctic Canada: a review
1999 Standout
Myocarditis
2009 Standout
Eosinophilic Myocarditis Temporally Associated With Conjugate Meningococcal C and Hepatitis B Vaccines in Children
2008
Successful Vaccine-Induced Seroconversion by Single-Dose Immunization in the Presence of Measles Virus-Specific Maternal Antibodies
2000
Making sense of epidemiological studies of young children exposed to thimerosal in vaccines
2010
Virus interactions with dendritic cells.
1999
Coverage of and Influences on Timely Administration of Hepatitis B Vaccine Birth Dose in Remote Rural Areas of the People’s Republic of China
2009
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Virus-lymphoid cell interactions
1996
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Improving health outcomes of the poor
2002
A Question of Balance
2008
Yellow fever vaccine
2005
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Diagnostics for the Developing World: Microfluidic Paper-Based Analytical Devices
2009 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Conceptualizing Stigma
2001 Standout
Safety and Immunogenicity of a Prototype EnterotoxigenicEscherichia coliVaccine Administered Transcutaneously
2002
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins
2002 StandoutNobel
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000 StandoutNobel
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
2003
Improving Vaccination Coverage in Urban Areas Through a Health Communication Campaign: The 1990 Philippines Experience
2002
Whole Tumor Antigen Vaccines: Where Are We?
2015
Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site Diagnosis
2008 Standout
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant
2007 StandoutNobel
Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.
1990
Understanding vaccination resistance: moving beyond risk
2003
Works of C. John Clements being referenced
An anthropological perspective on the acceptability of immunization services.
1990
Implementing the birth dose of hepatitis B vaccine in rural Indonesia
2007
The global impact of vaccines containing aluminium adjuvants
2002
A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries
2006
The Epidemiology of Measles: Thirty Years of Vaccination
1995
Progress in the control of hepatitis B infection in the Western Pacific Region
2005
Misled and confused? Telling the public about MMR vaccine safety: Table 1
2003
Ensuring vaccine safety in immunization programmes — a WHO perspective
2001
Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review
2003
Technologies that make administration of vaccines safer
2004
The evidence for the safety of thiomersal in newborn and infant vaccines
2003
Altenative Routes of Measles Immunization: a Review
1997
Measles immunization research: a review.
1989
Immunization of children at risk of infection with human immunodeficiency virus.
2003
HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND ROUTINE CHILDHOOD IMMUNISATION
1987
Principles of measles control.
1991